Adaptive Biotechnologies Corporation
ADPT
$9.29
-$0.22-2.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -141.84M | -159.49M | -195.24M | -213.47M | -215.06M |
| Total Depreciation and Amortization | 18.77M | 19.26M | 20.20M | 21.37M | 22.02M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 61.01M | 62.48M | 89.41M | 92.46M | 89.53M |
| Change in Net Operating Assets | -23.29M | -17.45M | -24.02M | -29.64M | -32.01M |
| Cash from Operations | -85.34M | -95.21M | -109.65M | -129.27M | -135.53M |
| Capital Expenditure | -3.41M | -3.66M | -4.88M | -7.32M | -9.28M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 62.27M | 81.46M | 63.76M | 87.05M | 120.46M |
| Cash from Investing | 58.86M | 77.79M | 58.88M | 79.73M | 111.18M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 5.65M | 241.00K | 201.00K | 178.00K | 1.62M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5.65M | 241.00K | 201.00K | 178.00K | 1.62M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.84M | -17.18M | -50.57M | -49.36M | -22.73M |